Navigation Links
Monsanto Executives to Address Investor Conferences in February
Date:2/5/2008

ST. LOUIS, Feb. 5 /PRNewswire-FirstCall/ -- Monsanto Company's (NYSE: MON) Brett Begemann, executive vice president of global commercial business, and Carl Casale, executive vice president of strategy and operations, will address investors in separate presentations at two conferences later this month.

Both Monsanto executives will provide an update on the company's business performance and expectations, strategic initiatives, product performance, research-and-development pipeline, and other business matters at these conferences. The conferences include:
-- Goldman Sachs' 2008 AgForum Conference: On Tuesday, Feb. 12, Monsanto's

Begemann will be presenting at Goldman Sachs' 2008 AgForum Conference

held in New York. Begemann's presentation will begin at 12:40 p.m. EST

(11:40 a.m. CT).

-- Morgan Stanley Basic Materials Conference 2008: Monsanto's Casale will

be presenting at the Morgan Stanley Basic Materials Conference 2008 on

Thursday, Feb. 21, in New York. Casale's presentation will begin at 8

a.m. EST (7 a.m. CT).

Presentation slides and simultaneous audio webcasts of the conference calls may be accessed by visiting the company's web site at http://www.monsanto.com/investors. Following the live broadcasts, Monsanto will archive the presentation slides and replays of the webcasts at the company's web site.

Monsanto Company is a leading global provider of technology-based solutions and agricultural products that improve farm productivity and food quality. For more information on Monsanto, see: http://www.monsanto.com.


'/>"/>
SOURCE Monsanto Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. National Academy of Sciences Recognizes Monsantos Chief Technology Officer for Development of Agricultural Biotechnology
2. Monsantos R&D Pipeline Set to Deliver Valuable Products to Farmers Well Into Next Decade
3. Monsanto and Devgen Describe New Approach to Insect-Protection
4. Monsanto Company Executives Adopt 10b5-1 Trading Plans
5. Science Magazine Recognizes Monsanto as Top Employer
6. Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results
7. Monsanto Company Sets Webcast and Analyst/Media Call for 2007 Fourth-Quarter and Fiscal-Year Financial Results
8. Monsanto and Evogene Collaborate on Nitrogen Use Efficiency Research
9. Monsanto Company Signs Share Subscription Agreement With Devgen
10. Brazilian National Biosafety Technical Committee Approves Monsanto Company Insect-Protected Corn Trait
11. Leading Pharmaceutical Communication Executives Gather for the 1st Annual Pharmaceutical Public Relations Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), ... announced its financial results for the fourth quarter and fiscal ... Highlights Total sales in the fourth ... increased by 13.6% in USD terms to $77.6 million from ... Gross profit increased by 13.3% to $46.8 million from ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... portfolio to include an array of biochemical analyses critical for Lead Discovery. ... drive their hit-to-lead and SAR programs, including inhibitor potency and selectivity, mechanism of ...
(Date:2/23/2017)...  Imanis Life Sciences announced today the launch ... viruses for virotherapy research. These viruses are licensed ... vaccinia virus-based technology platform for research use. ... partnership with Genelux to offer researchers, for the ... in research," said Dr. Kah Whye Peng ...
(Date:2/23/2017)... Winston-Salem, NC (PRWEB) , ... February 23, 2017 , ... ... pleased to announce a new partnership with Compass Research . GGI's mission is ... gifting a vaccine to a child in need in honor of each clinical trial ...
Breaking Biology Technology:
(Date:2/16/2017)... 16, 2017  Genos, a community for personal ... has received Laboratory Accreditation from the College of ... to laboratories that meet stringent requirements around quality, ... processes. "Genos is committed to maintaining ... We,re honored to be receiving CAP accreditation," said ...
(Date:2/10/2017)... Research and Markets has announced ... - Scientific and Commercial Aspects" to their offering. ... Biomarkers ... with therapy for selection of treatment as well for monitoring ... of disease in modern medicine. Biochip/microarray technologies and next generation ...
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 Report ... ... and should reach $11.4 billion by 2021, growing at a ... Report Includes - An overview of the global markets for ... from 2015, estimates for 2016, and projections of compound annual ...
Breaking Biology News(10 mins):